Financials
- Market Capitalization 24.88 B
- Employee 721
- Founded 2014
- CEO Matt Gline
- Website www.roivant.com
- Headquarter Bermuda
- FIGI N/A
- Industry Biotechnologies
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 387 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 280.55 USD | -0.25% | -12.05% | -2.63% | -9.86% | 37.46 B USD | ||
| 492 | MRNA Moderna, Inc. - Common Stock | 67.07 USD | -0.55% | -9.16% | +28.88% | +111.44% | 26.61 B USD | ||
| 523 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 55.40 USD | -0.49% | -4.32% | +2.06% | +48.68% | 24.63 B USD | ||
| 538 | INSM Insmed Incorporated - Common Stock | 109.12 USD | -0.90% | -4.62% | +11.92% | -32.66% | 23.65 B USD |